New hope for glaucoma patients suffering from dry, irritated eyes
NCT ID NCT04354545
Summary
This study is testing whether an FDA-approved eye drop called Xiidra can help relieve eye dryness and discomfort in people with glaucoma. The discomfort is often caused by the multiple daily eye pressure medications these patients must use. Researchers will measure changes in eye dryness and surface health over 12 weeks in 75 participants who are already being prescribed Xiidra as part of their regular care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Doheny Eye Center UCLA
RECRUITINGFountain Valley, California, 92708, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.